Literature DB >> 8560765

Evolution of canine parvovirus involved loss and gain of feline host range.

U Truyen1, J F Evermann, E Vieler, C R Parrish.   

Abstract

Canine parvovirus (CPV) type-2 emerged as a new virus infecting dogs in 1978, and it was probably derived as a variant of feline panleukopenia virus or of a closely related virus infecting another carnivore. CPV type-2 was subsequently replaced in nature by antigenically variant viruses (CPV type-2a and CPV type-2b) which now coexist in dog populations worldwide. We show that CPV type-2 isolates did not replicate in cats, but that both CPV type-2a and CPV type-2b isolates replicated efficiently. About 10% of the viruses isolated from cats with natural parvovirus disease were antigenically indistinguishable from CPV type-2a or type-2b. The capsid protein gene sequence of a 1990 feline parvovirus isolate ("FPV-24") was essentially identical to the sequence of CPV type-2b viruses from dogs. The loss and reacquisition of the feline host range in CPV was most likely due in each case to small numbers of changes in a region of the virus capsid where three protein monomers interact.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8560765     DOI: 10.1006/viro.1996.0021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  82 in total

1.  Evolutionary reversals during viral adaptation to alternating hosts.

Authors:  W D Crill; H A Wichman; J J Bull
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

2.  Development of a reverse genetics system for a feline panleukopenia virus.

Authors:  Nan Cheng; Yongkun Zhao; Qiuxue Han; Weijiao Zhang; Ji Xi; Yongle Yu; Hualei Wang; Guohua Li; Yuwei Gao; Songtao Yang; Weiquan Liu; Xianzhu Xia
Journal:  Virus Genes       Date:  2018-12-05       Impact factor: 2.332

3.  Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.

Authors:  Vito Martella; Alessandra Cavalli; Nicola Decaro; Gabriella Elia; Costantina Desario; Marco Campolo; Giancarlo Bozzo; Elvira Tarsitano; Canio Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Variable pleiotropic effects from mutations at the same locus hamper prediction of fitness from a fitness component.

Authors:  Kim M Pepin; Melanie A Samuel; Holly A Wichman
Journal:  Genetics       Date:  2005-12-15       Impact factor: 4.562

5.  Pathogenic potential of canine parvovirus types 2a and 2c in domestic cats.

Authors:  K Nakamura; M Sakamoto; Y Ikeda; E Sato; K Kawakami; T Miyazawa; Y Tohya; E Takahashi; T Mikami; M Mochizuki
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

6.  Evolution of CPV-2 and implication for antigenic/genetic characterization.

Authors:  Vito Martella; Nicola Decaro; Canio Buonavoglia
Journal:  Virus Genes       Date:  2006-08       Impact factor: 2.332

7.  Detecting small changes and additional peptides in the canine parvovirus capsid structure.

Authors:  Christian D S Nelson; Eveliina Minkkinen; Magnus Bergkvist; Karin Hoelzer; Mathew Fisher; Brian Bothner; Colin R Parrish
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice.

Authors:  Maria Kontou; Lakshmanan Govindasamy; Hyun-Joo Nam; Nathan Bryant; Antonio L Llamas-Saiz; Concepción Foces-Foces; Eva Hernando; Mari-Paz Rubio; Robert McKenna; José M Almendral; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

10.  Frequent cross-species transmission of parvoviruses among diverse carnivore hosts.

Authors:  Andrew B Allison; Dennis J Kohler; Karen A Fox; Justin D Brown; Richard W Gerhold; Valerie I Shearn-Bochsler; Edward J Dubovi; Colin R Parrish; Edward C Holmes
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.